A narrative review of intraoperative floppy iris syndrome: an update 2020

intraoperative floppy iris Syndrome : update 2012

α-BlOcKeRS anD iFiS Tamsulosin was reportedly introduced in Japan in 1993, in the United Kingdom in 1997, and in the United States in 1997. Gupta et al related the popularity of the drug to its high affinity for the α1A receptor, which explains the lower incidence of adverse cardiovascular events in patients taking tamsulosin compared with less selective α-adrenergic blockers.3 Additionally, th...

Intraoperative floppy-iris syndrome.

OBJECTIVE Intraoperative-floppy iris syndrome (IFIS) has been recently described. It has been demonstrated that this new syndrome complicates cataract surgery. In this paper we have reviewed the syndrome, and offer practical information specially related to the origin and management of this syndrome and we offer practical information. MATERIAL AND METHODS A review of the related medical liter...

The Intraoperative Floppy Iris Syndrome

A t the annual meeting of the ASCRS in April, John R. Campbell, MD, and I reported on two companion studies that we conducted to examine the incidence, characteristics, surgical outcomes, and etiology of floppy irides during cataract surgery.1,2 We named this condition the intraoperative floppy iris syndrome (IFIS) (Figures 1 to 3). Based upon retrospective observations by Dr. Campbell regardin...

ASCRS White Paper: clinical review of intraoperative floppy-iris syndrome.

Intraoperative floppy-iris syndrome (IFIS) is associated with the use of systemic alpha(1)-antagonists, and tamsulosin in particular. The incidence and severity of IFIS are variable; however, the syndrome is associated with a higher rate of cataract surgical complications, especially when the condition is not recognized or anticipated. Questioning cataract patients preoperatively about current ...

Silodosin-associated intraoperative floppy iris syndrome